Dr Gideon Hirschfield from the University of Toronto Centre for Liver Disease discusses the potential of new drugs, including selective PPAR agents such as seladelpar, for the treatment of primary biliary cholangitis.

Progress in PBC: Gideon Hirschfield, MD

The Gastroenterology Learning Network is an online resource for the latest developments in gastroenterology practice, providing a customized experience for users to stay informed about the topics that matter most to them, including inflammatory bowel disease, hepatitis, and ulcerative colitis.

Share Progress in PBC: Gideon Hirschfield, MD

Sign up to save your podcasts

Progress in PBC: Gideon Hirschfield, MD

Progress in PBC: Gideon Hirschfield, MD

More shows like Gastroenterology Learning Network

Hidden Brain

Marketplace

JAMA Editors' Summary

NEJM This Week

JAMA Clinical Reviews

American Journal of Gastroenterology Author Podcasts

The Curbsiders Internal Medicine Podcast

Core IM | Internal Medicine Podcast

The Indicator from Planet Money

Annals On Call Podcast

JAMA Medical News

Infectious Disease Puscast

Critical Care Time

Gastroenterology Learning Network

Evidence-Based GI: An ACG Publication and Podcast